Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(146 Videos)

Education
(9 Videos)
Innovation
(0 Videos)
Leadership
(3 Videos)
OrthoJoe
(21 Videos)
Other
(14 Videos)
Personal Growth
(1 Videos)
Practice
(2 Videos)
Research
(20 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

See all (5)

Region of the Body

See all (5)

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 9 results matching your search query: "Procter & Gamble"

Showing 1 - 9 of 9
Read Ace Report

Biochemical markers of bone and cartilige degradation associated with progression of OA

Osteoarthritis Cartilage. 2008 Jun;16(6):660-6. Epub 2007 Nov 13.

RCT General Orthopaedics Osteoarthritis Lower Extremity Knee Joint Medial Compartment Arthritis Cartilage Procter & Gamble Risedronate - Hide
Read Ace Report

Zoledronic acid reduces rates of new clinical fractures after hip fracture repair

N Engl J Med. 2007 Nov 1;357(18):1799-809. Epub 2007 Sep 17

RCT Trauma Lower Extremity Hip Fracture Amgen Aventis Novartis Procter & Gamble Sanofi Placebo Zoledronic Acid - Hide
Read Ace Report

Denosumab reduces risk of fractures in post-menopausal women

N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Axial Skeleton Spine Spine Lumbar Fracture Amgen AstraZeneca Aventis Eli Lilly GlaxoSmithKline Merck Nordic Bioscience Novartis Procter & Gamble Roche Sanofi Denosumab Placebo Subcutaneous Injection - Hide
Read Ace Report

Substantial anti-resorptive effects achieved with 1mg and 2.5mg doses of zoledronate

J Clin Endocrinol Metab. 2012 Jan;97(1):286-92. doi: 10.1210/jc.2011-2081. Epub 2011 Nov 9

RCT General Orthopaedics Osteopenia Postmenopausal Women Zoledronate IV Infusion Placebo - Hide
Read Ace Report

Effects of 2.5mg zoledronate are long-lasting and similar to 5mg dose in osteopenic women

J Bone Miner Res. 2014 Jan;29(1):166-72. doi: 10.1002/jbmr.2009.

RCT General Orthopaedics Osteopenia Postmenopausal Women Axial Skeleton Spine Spine Lumbar Lower Extremity Hip Novartis Roche Zoledronate Infusion Placebo - Hide
Read Ace Report

Antiresorptive effects of single zoledronate dose are sustained for 3 years

J Bone Miner Res. 2010 Oct;25(10):2251-5

RCT Metabolic Disorders Osteopenia Postmenopausal Women Zoledronate Placebo - Hide
Read Ace Report

Five-year follow-up of the effects of calcium supplementation in postmenopausal women

Osteoporos Int. 2014 Jan;25(1):297-304. doi: 10.1007/s00198-013-2526-z. Epub 2013 Oct 10.

RCT Metabolic Disorders Postmenopausal Women Fracture Calcium Placebo - Hide
Read Ace Report

Significant reduction in 6-year fragility fracture risk with zoledronate vs placebo for osteopenia

N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082

RCT Metabolic Disorders Elderly Osteopenia Postmenopausal Women Lower Extremity Hip Bone Femur Neck Fracture Novartis Zoledronate Intravenous Infusion Placebo - Hide
Read Ace Report

An evaluation of the cost-effectiveness of arthroscopy in knee osteoarthritis

BMJ Open. 2016 Jan 12;6(1):e009949.

RCT Osteoarthritis Lower Extremity Knee Arthritis Arthroscopic Arthroscopy Debridement Non-Operative Medical Physical Therapy - Hide
Showing 1 - 9 of 9